{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:16:51Z","timestamp":1792073811624,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013150","name":"Scientific Research and Sharing Platform Construction Project of Shaanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.metabol.2024.156036","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:26:06Z","timestamp":1727457966000},"page":"156036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["PDCD4 deficiency in hepatocytes exacerbates nonalcoholic steatohepatitis through enhanced MHC class II transactivator expression"],"prefix":"10.1016","volume":"161","author":[{"given":"Kaikai","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengda","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianying","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2024.156036_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) \u2014 pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.metabol.2024.156036_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101238","article-title":"Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): recent advances","volume":"91","author":"Musso","year":"2023","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2024.156036_bb0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156036_bb0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156036_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155835","article-title":"Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges","volume":"154","author":"Kokkorakis","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156036_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155936","article-title":"Metabolic dysfunction-associated steatotic liver disease: recent turning points for its diagnosis and management","volume":"157","author":"Polyzos","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156036_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155975","article-title":"Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: a narrative review","volume":"158","author":"Afonso","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156036_bb0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.freeradbiomed.2020.06.016","article-title":"Programmed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer","volume":"159","author":"Lu","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2024.156036_bb0045","first-page":"7","article-title":"Pdcd4 restrains the self-renewal and white-to-beige transdifferentiation of adipose-derived stem cells","author":"Bai","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2024.156036_bb0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10495-013-0830-x","article-title":"Decrease of apoptosis markers during adipogenic differentiation of mesenchymal stem cells from human adipose tissue","volume":"18","author":"Lo Furno","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.metabol.2024.156036_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111562","article-title":"Pdcd4 promotes lipid deposition by attenuating PPAR\u03b1-mediated fatty acid oxidation in hepatocytes","volume":"545","author":"Du","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2024.156036_bb0060","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.2337\/db13-0097","article-title":"Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance","volume":"62","author":"Wang","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156036_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110529","article-title":"PRMT5 knockdown enhances cell viability and suppresses cell apoptosis, oxidative stress, inflammation and endothelial dysfunction in ox-LDL-induced vascular endothelial cells via interacting with PDCD4","volume":"122","author":"Fei","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.metabol.2024.156036_bb0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/labinvest.2012.174","article-title":"The inhibitory action of PDCD4 in lipopolysaccharide\/d-galactosamine-induced acute liver injury","volume":"93","author":"Wang","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.metabol.2024.156036_bb0075","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.7660125","article-title":"Inducible gene targeting in mice","volume":"269","author":"Kuhn","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.metabol.2024.156036_bb0080","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.85.14.5166","article-title":"Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1","volume":"85","author":"Sauer","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2024.156036_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.589771","article-title":"High-fat diet alters the expression of reference genes in male mice","volume":"7","author":"Fan","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.metabol.2024.156036_bb0090","first-page":"9","article-title":"microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4","author":"Li","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.metabol.2024.156036_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115546","article-title":"Optimizing component formula suppresses lung cancer by blocking DTL-mediated PDCD4 ubiquitination to regulate the MAPK\/JNK pathway","volume":"299","author":"Fan","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2024.156036_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114532","article-title":"Discovery of dearomatized isoprenylated acylphloroglucinols with colon tumor suppressive activities in mice via inhibiting NF\u03baB-FAT1-PDCD4 signaling activation","volume":"239","author":"Jiang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.metabol.2024.156036_bb0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.omtn.2023.07.013","article-title":"Tumor targeting and therapeutic assessments of RNA nanoparticles carrying a9-nAChR aptamer and anti-miR-21 in triple-negative breast cancers","volume":"33","author":"Liao","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.metabol.2024.156036_bb0110","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2024.156036_bb0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2024.156036_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.alcohol.2019.08.008","article-title":"Overexpression of MHCII by hepatocytes in alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH) and normal controls","volume":"84","author":"Lu","year":"2020","journal-title":"Alcohol"},{"key":"10.1016\/j.metabol.2024.156036_bb0125","first-page":"46","article-title":"The NLR member CIITA: master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy","author":"Forlani","year":"2023","journal-title":"Biom J"},{"key":"10.1016\/j.metabol.2024.156036_bb0130","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1073\/pnas.0712235105","article-title":"PDCD4 inhibits translation initiation by binding to elF4A using both its MA3 domains","volume":"105","author":"Suzuki","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2024.156036_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/boc.201800014","article-title":"The role of Pdcd4 in tumour suppression and protein translation","volume":"110","author":"Wang","year":"2018","journal-title":"Biol Cell"},{"key":"10.1016\/j.metabol.2024.156036_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coi.2016.02.009","article-title":"Staying local \u2014 antigen presentation in the liver","volume":"40","author":"Knolle","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.metabol.2024.156036_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00635","article-title":"The contribution of non-professional antigen-presenting cells to immunity and tolerance in the liver","volume":"9","author":"Mehrfeld","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2024.156036_bb0150","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","article-title":"Biological consequences of MHC-II expression by tumor cells in cancer","volume":"25","author":"Axelrod","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.metabol.2024.156036_bb0155","article-title":"CD4+ T cell activation and inflammation in NASH-related fibrosis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2024.156036_bb0160","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.immuni.2023.04.005","article-title":"cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity","volume":"56","author":"Zhao","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2024.156036_bb0165","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jhep.2003.50191","article-title":"MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes","volume":"37","author":"Herkel","year":"2003","journal-title":"Hepatology"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524002646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524002646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:14:07Z","timestamp":1731690847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524002646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"alternative-id":["S0026049524002646"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156036","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDCD4 deficiency in hepatocytes exacerbates nonalcoholic steatohepatitis through enhanced MHC class II transactivator expression","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156036"}}